| +0.15 / +0.29%|
The 20 analysts offering 12-month price forecasts for ResMed Inc have a median target of 52.13, with a high estimate of 64.96 and a low estimate of 39.00. The median estimate represents a +0.45% increase from the last price of 51.90.
The current consensus among 23 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since August, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.